Fig. 1.
Alteration in PD-L1 expression on tumour cells after drug therapy or concurrent chemo-radiotherapy. PD-L1 programmed death ligand-1, TPS tumour proportion score, CT chemotherapy, cCRT concurrent chemo-radiotherapy
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.